Future prospective studies are also needed to confirm these results and answer more difficult questions about the appropriate period to start GH therapy after achieving complete remission, and how to deal with children with “chronic” low-grade tumor diseases and growth hormone deficiency (GHD). The gene discussed is GH1; the disease is neoplasm.